Drew Young

Senior Vice President and U.S. Franchise Head of Neurology & Immunology


Profile

Drew Young is the Senior Vice President and U.S. Franchise Head of Neurology & Immunology (N&I) at EMD Serono. In this role, Drew is responsible for leading the Commercial strategy and operations for all N&I products.

Working in the pharmaceutical and biotech industry for more than 25 years, Drew has significant experience leading commercial teams across various therapeutic areas and geographies with an expertise in the N&I space. He has achieved success in establishing business operations and driving product performance.

Drew first joined EMD Serono in 2014 as Senior Vice President, U.S. Neurology and Immunology where he generated new organizational confidence across the business while regaining market leadership in the interferon category.

He then served as Managing Director for the company in Australia and New Zealand where he helped lead launch preparations for products in Multiple Sclerosis and merkel cell carcinoma, identifying opportunities to expand the Fertility portfolio, strengthening relationships with key government officials and advocacy partners and expanding the company’s footprint in New Zealand. Most recently, as Global Commercial Head for the newest product in the global MS franchise, he helped create plans for top markets around the world and provided guidance to improve payer access.

Prior to EMD Serono, Drew held a variety of Commercial leadership roles at Bristol-Myers Squibb in both Canada and the U.S., as well as at Biogen and Novartis.

He graduated from McGill University in Montreal, Canada with a bachelor’s degree in Business and Managerial Economics, where he was also the recipient of the Scarlet Key Award for outstanding student leadership.

Redirect

You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement